Hyaluronan oligosaccharides promote diabetic wound healing by increasing angiogenesis

Pharmacological Reports

Volumn 68, Issue 6, 2016, Pages 1126-1132

  Wang, Yi ^a   Han, Guanying ^a   Guo, Bin ^a   Huang, Jianhua ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Diabetic wound healing; Hyaluronan oligosaccharides

Indexed keywords

ACTIN; ANGIOGENESIS MODULATOR; CD31 ANTIGEN; COLLAGEN; GLUCOSE; HERMES ANTIGEN; HYALURONAN OLIGOSACCHARIDE; HYALURONIC ACID DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; OLIGOSACCHARIDE; TOPICAL AGENT; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; WOUND HEALING PROMOTING AGENT; HYALURONIC ACID; OINTMENT;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; OINTMENT; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TOPICAL TREATMENT; UMBILICAL VEIN ENDOTHELIAL CELL; WOUND HEALING; ADMINISTRATION AND DOSAGE; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYALURONIC ACID; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; OINTMENTS; OLIGOSACCHARIDES; RATS; RATS, SPRAGUE-DAWLEY; WOUND HEALING;

EID: 84992121935     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2016.07.001     Document Type: Article

References (24)

1. [1] Reinke, J.M., Sorg, H., Wound repair and regeneration. Eur Surg Res 49:1 (2012), 35–43.
2. [2] Xu, F., Zhang, C., Graves, D.T., Abnormal cell responses and role of TNF-α in impaired diabetic wound healing. Biomed Res Int, 2013, 2013, 754802.
3. [3] Martin, A., Komada, M.R., Sane, D.C., Abnormal angiogenesis in diabetes mellitus. Med Res Rev 23:2 (2003), 117–145.
4. [4] O'Loughlin, A., Kulkarni, M., Creane, M., Vaughan, E.E., Mooney, E., Shaw, G., et al. Topical administration of allogeneic mesenchymal stromal cells seeded in a collagen scaffold augments wound healing and increases angiogenesis in the diabetic rabbit ulcer. Diabetes 62:7 (2013), 2588–2594.
5. [5] American Diabetes Association, Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008; 31(13):596–615.
6. [6] Brinck, J., Heldin, P., Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44. Exp Cell Res 252:2 (1999), 342–351.
7. [7] Feinberg, R.N., Beebe, D.C., Hyaluronate in vasculogenesis. Science 220:4602 (1983), 1177–1179.
8. [8] Slevin, M., Krupinski, J., Gaffney, J., Matou, S., West, D., Delisser, H., et al. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol 26:1 (2007), 58–68.
9. [9] Gao, F., Liu, Y., He, Y., Yang, C., Wang, Y., Shi, X., et al. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol 29:2 (2010), 107–116.
10. [10] Gao, F., Yang, C.X., Mo, W., Liu, Y.W., He, Y.Q., Hyaluronan oligosaccharides are potential stimulators to angiogenesis via RHAMM mediated signal pathway in wound healing. Clin Invest Med 31:3 (2008), E106–16.
11. [11] Yang, M., Sheng, L., Zhang, T.R., Li, Q., Stem cell therapy for lower extremity diabetic ulcers: where do we stand?. Biomed Res Int, 2013, 2013, 462179.
12. [12] Stern, R., Hyaluronan catabolism: a new metabolic pathway. Eur J Cell Biol 83:7 (2004), 317–325.
13. [13] West, D.C., Hampson, I.N., Arnold, F., Kumar, S., Angiogenesis induced by degradation products of hyaluronic acid. Science 4705:228 (1985), 1324–1326.
14. [14] Slevin, M., West, D., Kumar, P., Rooney, P., Kumar, S., Hyaluronan, angiogenesis and malignant disease. Int J Cancer 109:5 (2004), 793–794 author rely 795-6.
15. [15] Rooney, P., Kumar, S., Ponting, J., Wang, M., The role of hyaluronan in tumour neovascularization (review). Int J Cancer 60:5 (1995), 632–636.
16. [16] Galeano, M., Polito, F., Bitto, A., Irrera, N., Campo, G.M., Avenoso, A., et al. Systemic administration of high-molecular weight hyaluronan stimulates wound healing in geneticallydiabetic mice. Biochim Biophys Acta 1812:7 (2011), 752–759.
17. [17] Hall, C.L., Lange, L.A., Prober, D.A., Zhang, S., Turley, E.A., pp60(c-src) is required for cell locomotion regulated by the hyaluronanreceptor RHAMM. Oncogene 13:10 (1996), 2213–2224.
18. [18] Slevin, M., Krupinski, J., Kumar, S., Gaffney, J., Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest 78:8 (1998), 987–1003.
19. [19] Nandi, A., Estess, P., Siegelman, M.H., Hyaluronan anchoring and regulation on the surface of vascular endothelial cells is mediated through the functionally active form of CD44. J Biol Chem 275:20 (2000), 14939–14948.
20. [20] Lokeshwar, V.B., Selzer, M.G., Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. J Biol Chem 275:36 (2000), 27641–27649.
21. [21] Savani, R.C., Cao, G., Pooler, P.M., Zaman, A., Zhou, Z., DeLisser, H.M., Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem 276:39 (2001), 36770–36778.
22. [22] Galeano, M., Polito, F., Bitto, A., Irrera, N., Campo, G.M., Avenoso, A., et al. Systemic administration of high-molecular weight hyaluronan stimulates wound healing in genetically diabetic mice. Biochim Biophys Acta. 1812:7 (2011), 752–759.
23. [23] Schlessinger, J., New roles for Src kinases in control of cell survival and angiogenesis. Cell 100:3 (2000), 293–296.
24. [24] Sun, Y., Liu, W.Z., Liu, T., Feng, X., Yang, N., Zhou, H.F., Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res 35:6 (2015), 600–604.